GlassScriptPhysician profile
Joseph Morgan
NPI 1982229100
$360.50
in general payments reported to CMS, 2019-2025
9 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.46 · 2022: $39.79 · 2023: $16.08 · 2024: $69.11 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $109.84 | 2025 | Assure Wcd |
| Cvrx, INC. | $86.50 | 2024-2025 | Barostim Neo System |
| Pulmonx Corporation | $40.80 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Novartis Pharmaceuticals Corporation | $39.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.41 | 2025 | |
| Medtronic, INC. | $18.41 | 2024 | Linq II |
| Inogen, INC. | $16.08 | 2023 | Inogen |
| Glaxosmithkline, LLC. | $14.21 | 2025 | Nucala |
| Janssen Pharmaceuticals, INC | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.